InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-12.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Roemer Alan S., Director. Director active across 2 companies, notably NexImmune, Inc.. Aggregated, 7 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €49k. History available since 16 August 2022. The latest transaction was disclosed on 22 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
36,232 shares@ US$1.38Common StockSEC:0001643070-25-000005:0
102,459 shares@ US$0.184425.3% of flowCommon StockSEC:0001415889-25-012287:0
126,582 sharesCommon StockSEC:0001415889-24-024868:0
102,459 sharesCommon StockSEC:0001209191-23-058719:0
3,833 shares@ €1.975312.3% of flowCommon StockSEC:0001209191-23-056514:0
26,315 shares@ US$1.9074.7% of flowCommon StockSEC:0001209191-22-046600:0
Ideal exit: 13 May 2023 (T+270)
12,634 shares@ €2.145950.0% of flowCommon StockSEC:0001209191-21-070944:0
7 of 7 declarations
About Roemer Alan S.
Alan S. Roemer is a Director at NexImmune, Inc. He participates in the governance of the company and in defining its strategy to promote innovation in the biotechnology sector.
